CATALYST PHARMACEUTICAL PARTNERS, INC. 4,000,000 shares of Common Stock and Warrants to purchase up to 1,200,000 shares of Common Stock PLACEMENT AGENT AGREEMENTCatalyst Pharmaceutical Partners, Inc. • August 28th, 2012 • Pharmaceutical preparations • California
Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the purchasers, pursuant to the terms and conditions of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), up to an aggregate of (i) 4,000,000 authorized but unissued shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and (ii) warrants (the “Warrants”) to purchase up to 1,200,000 shares of Common Stock (the “Warrant Shares”). The form of the Warrant is attached hereto as Exhibit B. The Shares, the Warrants and the Warrant Shares are collectively referred to as the “Securities.” The Company hereby confirms its agreement with Roth Capital Partners, LLC (the “Placement Agent”) to act as Placement Agent in accordance wit
Catalyst Pharmaceutical Partners, Inc. Coral Gables, Florida 33134 Gentlemen:Catalyst Pharmaceutical Partners, Inc. • August 28th, 2012 • Pharmaceutical preparations • New York
The undersigned (the “Investor”) hereby confirms its agreement with Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), as follows:
